News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AtriCure, Inc. (ATRC) Release: Promising Mid-Term Results From Thoracoscopic Ablation of Persistent Atrial Fibrillation Presented at Meeting of International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)


6/18/2013 9:19:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PRAGUE--(BUSINESS WIRE)--A leading German cardiovascular heart center reported promising mid-term results for the surgical treatment of persistent atrial fibrillation (Afib) during last week’s International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) meeting being held in Prague, Czech Republic. At three-year follow-up, 80 percent of persistent Afib patients were free from Afib and off anti-arrhythmic medications using AtriCure’s Bipolar RF Ablation System. These results compare favorably with a more commonly performed, catheter-based approach. The team at Sana Heart Center in Stuttgart, Germany performed the beating heart thoracoscopic surgical procedures under the guidance of Professor Nicolas Doll, Chief of Cardiovascular Surgery at Sana.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES